Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.33
-0.11 (-2.02%)
Aug 15, 2025, 2:29 PM - Market open
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $10.22 million as of August 15, 2025. Its market cap has decreased by -63.30% in one year.
Market Cap
10.22M
Enterprise Value
-216.08K
1-Year Change
-63.30%
Ranking
Category
Stock Price
$5.33
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $10.22M, a decrease of -98.52%. That is a compound annual growth rate of -60.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2025 | 10.43M | -49.08% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | 690.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 620.78B |
| Johnson & Johnson | 423.39B |
| AbbVie | 362.73B |
| UnitedHealth Group | 279.16B |
| AstraZeneca | 243.29B |
| Novartis AG | 236.22B |
| Abbott Laboratories | 228.94B |
| Novo Nordisk | 225.09B |